139 related articles for article (PubMed ID: 31016254)
1. A new
Maladan Y; Krismawati H; Hutapea HML; Oktavian A; Fatimah R; Widodo
Heliyon; 2019 Mar; 5(3):e01279. PubMed ID: 31016254
[TBL] [Abstract][Full Text] [Related]
2. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.
Williams DL; Spring L; Harris E; Roche P; Gillis TP
Antimicrob Agents Chemother; 2000 Jun; 44(6):1530-7. PubMed ID: 10817704
[TBL] [Abstract][Full Text] [Related]
3. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
4. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
5. Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy.
Chaitanya V S; Das M; Bhat P; Ebenezer M
J Cell Biochem; 2015 Oct; 116(10):2293-303. PubMed ID: 25833404
[TBL] [Abstract][Full Text] [Related]
6. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
7. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
Chen X; He J; Liu J; You Y; Yuan L; Wen Y
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007946. PubMed ID: 31881061
[TBL] [Abstract][Full Text] [Related]
8. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
Kai M
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
[TBL] [Abstract][Full Text] [Related]
9. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
10. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
Gillis TP; Williams DL
Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of natural compounds on Dihydropteroate synthase of
Khan M; Khan S; Bushara NZA; Ali R; Tabassum Z; Ishrat R; Marouf HA; Sherwani S; Mirza S; Haque S
J Biomol Struct Dyn; 2023; 41(23):13857-13872. PubMed ID: 37070201
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
14. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene.
Kai M; Matsuoka M; Nakata N; Maeda S; Gidoh M; Maeda Y; Hashimoto K; Kobayashi K; Kashiwabara Y
FEMS Microbiol Lett; 1999 Aug; 177(2):231-5. PubMed ID: 10474189
[TBL] [Abstract][Full Text] [Related]
15. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
[TBL] [Abstract][Full Text] [Related]
17. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
[TBL] [Abstract][Full Text] [Related]
18. Multiple docking analysis and
Halder ST; Dhorajiwala TM; Samant LR
Int J Mycobacteriol; 2019; 8(3):229-236. PubMed ID: 31512598
[TBL] [Abstract][Full Text] [Related]
19. Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.
Chauffour A; Lecorche E; Reibel F; Mougari F; Raskine L; Aubry A; Jarlier V; Cambau E;
Clin Microbiol Infect; 2018 Nov; 24(11):1213.e5-1213.e8. PubMed ID: 29906598
[TBL] [Abstract][Full Text] [Related]
20. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]